Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers.

Byrski, T; Gronwald, J; Huzarski, T; Grzybowska, E; Budryk, M; Stawicka, M; Mierzwa, T; Szwiec, M; Wisniowski, R; Siolek, M; Narod, S A; Lubinski, J

Byrski, T; Gronwald, J; Huzarski, T; Grzybowska, E; Budryk, M; Stawicka, M; Mierzwa, T; Szwiec, M; Wisniowski, R; Siolek, M; Narod, S A; Lubinski, J.

Affiliation

Byrski T; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.

Breast Cancer Res Treat ; 108(2): 289-96, 2008 Mar.

Article in En | MEDLINE | ID: mdl-17492376

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; BRCA1 Protein/genetics; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Gene Expression Regulation, Neoplastic; Adult; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents, Phytogenic/administration & dosage; Breast Neoplasms/pathology; Case-Control Studies; Chemotherapy, Adjuvant; Docetaxel; Doxorubicin/administration & dosage; Drug Resistance, Neoplasm/genetics; Female; Germ-Line Mutation; Humans; Middle Aged; Neoadjuvant Therapy; Patient Selection; Poland; Registries; Taxoids/administration & dosage; Treatment Outcome; Tubulin Modulators/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic / BRCA1 Protein Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Breast Cancer Res Treat Year: 2008 Document type: Article Affiliation country: Poland Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links